Shape Pfizer International Commercial Digital & AI portfolio to deliver the strongest possible risk-adjusted return. Give the Investment Committee an independent view of where capital should be committed, continued, redirected or stopped, based on the performance and risk profile of the portfolio as a whole, not only the merits of individual investments. This role holds the financial and portfolio-management integrity of the investment process and works in close partnership with the GCA International Value & Measurement CoE to ensure that measurement frameworks, methods and evidence are rigorous, comparable and decision-ready.
Define the budget and expected financial impact of each proposal at the outset. Translate the agreed KPIs into a financial value where conversion is defensible and into a documented impact score where it is not.
- Partner with the GCA International Value & Measurement CoE to ground KPI targets and expected financial impact in external evidence, including competitive intelligence, quantitative industry benchmarks and qualitative intelligence on the strategic actions of relevant peers.
- Own the independent portfolio audit at three, six and twelve months, drawing on measurement delivered or validated by the GCA International Value & Measurement CoE and other relevant data owners. Maintain the benefits ledger: promised value versus verified value, split into verified, written off, not yet audited and overdue.
- Own the portfolio risk-return view. Assess expected and realised return, concentration of risk, the balance between near-term value and longer-term optionality, and exposure across markets, archetypes, capabilities and investment stages. Show how different allocation choices affect expected return, risk, speed to value, strategic coverage and available capacity, and make the opportunity cost of each material decision visible before capital is committed.
- Translate performance evidence into active capital reallocation. Use stage-gate results, audits, changes in risk and emerging opportunities to recommend movement of funding across initiatives rather than allowing the original allocation to become permanent by default.
- Attach risk to individual decisions and to the portfolio as a whole.
- Own end-to-end programme and project management for value measurement and portfolio review. Set the audit calendar, secure inputs from the GCA International Value & Measurement CoE and other data owners, manage dependencies and data-quality risks, escalate gaps, and drive every review to a documented decision and closure. Determines the portfolio risk-return assessment and recommends changes in allocation, funding sequence, exposure and continuation. Significant relevant experience in finance, portfolio analytics, corporate planning, performance management, investment analysis, management consulting or a related field; (Demonstrated ownership of business cases or portfolio decisions that were subsequently audited against realised value.
- Comfortable with capital allocation at portfolio level, including risk-adjusted return, allocation across categories, concentration risk, opportunity cost and trade-offs between near-term return and longer-term optionality.
- Demonstrated ability to manage value at portfolio level, not only evaluate individual business cases. Able to use internal performance evidence alongside external competitive intelligence, quantitative industry benchmarks and qualitative peer intelligence without creating false comparability or overstating the precision of available evidence.
- Independent-minded and able to challenge a senior sponsor when the evidence does not support the claim.
- Able to navigate the GCA International Value & Measurement CoE, Finance, KPI governance, data owners and leadership-reporting structures to establish one consistent measurement basis and obtain reliable inputs.
- Can make complex financial, measurement and portfolio analysis decision-ready for leaders who will not read the underlying model.
- Experienced in setting standards and influencing resource-allocation decisions across a matrix without owning the underlying data, measurement resources or delivery teams.
Digital Transformation Strategy
One bold way we are achieving our purpose is through our company wide digital transformation strategy. We are leading the way in adopting new data, modelling and automated solutions to further digitize and accelerate drug discovery and development with the aim of enhancing health outcomes and the patient experience.
We aim to create a trusting, flexible workplace culture which encourages employees to achieve work life harmony, attracts talent and enables everyone to be their best working self. We believe that a diverse and inclusive workforce is crucial to building a successful business. As an employer, Pfizer is committed to celebrating this, in all its forms – allowing for us to be as diverse as the patients and communities we serve. DisAbility Confident
We are proud to be a Disability Confident Employer and we encourage you to put your best self forward with the knowledge and trust that we will make any reasonable adjustments necessary to support your application and future career. Your journey with Pfizer starts here!
To learn more about acceptable and prohibited uses of AI during the recruitment process, please review our candidate AI-use guidelines available on Pfizer Careers.
Information & Business Tech
Performance Analysis Manager in Wakefield employer: Pfizer
At Pfizer, we pride ourselves on being an exceptional employer, offering a dynamic and inclusive work culture that prioritises employee well-being and professional growth. Our hybrid work model fosters flexibility, allowing you to balance your personal and professional life while contributing to groundbreaking advancements in healthcare. With a commitment to diversity and a focus on empowering our employees, you'll find meaningful opportunities to make a real impact in the lives of patients around the world.
